EDITORIAL In the news : - Truffle Capital
EDITORIAL In the news : - Truffle Capital
EDITORIAL In the news : - Truffle Capital
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>In</strong> <strong>the</strong> <strong>news</strong> :<br />
• Highlight<br />
‐ <strong>Truffle</strong> 100 Europe<br />
• <strong>Truffle</strong> in <strong>the</strong> <strong>news</strong><br />
‐ Sandrine Gasnot joins<br />
<strong>Truffle</strong> capital<br />
• Portfolio News<br />
‐ <strong>In</strong>formation Technology:<br />
PeopleCube, MoMac<br />
Keyyo<br />
‐ Life Sciences :<br />
Néovacs, Carmat, Symetis,<br />
Deinove<br />
‐ Energy :<br />
2‐B Energy, SP3H, Neelogy,<br />
Acerde, Actility, RF‐iT<br />
• Contacts<br />
1 October 20, 2010<br />
2 Dow Jones Venture Source, July 2010<br />
<strong>EDITORIAL</strong><br />
N°17 - October 2010<br />
<strong>Truffle</strong> <strong>Capital</strong> ‐ 5, rue de la Baume 75008 Paris ‐ Tel: +33 1 47 20 22 20 ‐ www.truffle.com<br />
Following <strong>the</strong> success of two recent stock market<br />
listings (€10 million raised on April 15th by <strong>the</strong><br />
<strong>the</strong>rapeutic vaccines company Neovacs and €12<br />
million raised on April 21st by <strong>the</strong> greentech biofuel<br />
start‐up Deinove), <strong>Truffle</strong> <strong>Capital</strong> chalked up its 3rd<br />
successful IPO in 2010 after Carmat (a French<br />
company developing a total artificial implantable<br />
heart) listed on <strong>the</strong> NYSE Euronext Paris Alternext market.<br />
Despite tough market conditions, Carmat raised €16.5 million (€18.75 per share),<br />
which corresponds to <strong>the</strong> typical amount for this type of transaction. <strong>Truffle</strong> <strong>Capital</strong><br />
is Carmat’s co‐founder (along with EADS and <strong>the</strong> Fondation Carpentier), <strong>the</strong><br />
company’s main shareholder (with 31.8% of <strong>the</strong> post‐money stock) and <strong>the</strong> sole<br />
venture capital investor (€5 million invested in 2008, €1 million in 2009 and €2<br />
million this year).<br />
Since <strong>the</strong> IPO, market interest in <strong>the</strong> company has grown and Carmat has already<br />
achieved a market cap of €94 million 1 . This is one of <strong>the</strong> most striking performances<br />
ever on Alternext and benefits both <strong>the</strong> direct shareholders and <strong>the</strong> investors who<br />
entrusted <strong>the</strong>ir capital to <strong>Truffle</strong>'s funds.<br />
Carmat seems to have all <strong>the</strong> key factors for stock market success: cutting edge<br />
technology, a highly innovative product, a quality management team led by<br />
Marcello Conviti and Patrick Coulombier, strong medical demand and a high‐<br />
potential market with clear short‐term deadlines. The key milestone will be <strong>the</strong> first<br />
implantations in patients, scheduled for late 2011.<br />
According to Dow Jones Venture Source, 2010 has already witnessed 8 IPOs by<br />
companies backed by VC investors, raising a total of €93 million 2 . With €38 million<br />
raised so far, <strong>Truffle</strong> <strong>Capital</strong> accounts for 40% of <strong>the</strong> total and has thus confirming its<br />
solid position among Europe's leading venture capital firms.<br />
Henri Moulard, Jean-François Fourt, Dr Philippe Pouletty, Bernard-Louis Roques<br />
<strong>Truffle</strong> <strong>Capital</strong> is an independent European venture capital firm established in 2002, with a<br />
share capital of €1.7 million. We manage funds over €430 million, of which €210 million<br />
came from FCPIs.
HIGHLIGHT<br />
N°17 October 2010<br />
TRUFFLE CAPITAL UNVEILS THE FIFTH EDITION OF THE TRUFFLE 100 EUROPE<br />
<strong>Truffle</strong> <strong>Capital</strong> publishes its 5th annual ranking of <strong>the</strong><br />
top 100 European software companies at ICT 2010 in<br />
Brussels, <strong>the</strong> biggest European forum dedicated to<br />
digital research and innovation.<br />
The <strong>Truffle</strong> 100 Europe has been drawn up with <strong>the</strong><br />
support of Neelie Kroes (European Commissioner for<br />
<strong>the</strong> Digital Agenda) and Syntec <strong>In</strong>formatique and in<br />
collaboration with analysts IDC (www.idc.com) and<br />
CXP (www.cxp.fr), who performed <strong>the</strong> survey on<br />
which <strong>the</strong> ranking is based.<br />
"The latest edition of <strong>the</strong> <strong>Truffle</strong> 100 Europe<br />
emphasizes <strong>the</strong> dynamism of <strong>the</strong> European software<br />
industry in what is never<strong>the</strong>less a difficult economic<br />
climate.<br />
Key figures from <strong>the</strong> <strong>Truffle</strong> 100 Europe:<br />
• Total turnover for 2009 was €27.1 billion, compared<br />
with €25 billion in 2008. 79% of this figure was<br />
generated by <strong>the</strong> ranking's top 25 companies (down<br />
from 70% in 2008).<br />
• The mean growth in turnover was 8.4% in 2009<br />
• 47 vendors posted revenues of over €100 million and<br />
72 vendors earned over €50 million. All <strong>Truffle</strong> 100<br />
Europe companies had revenues of over €25 million.<br />
• Profits rose from €3.6 billion in 2008 to €3.7 billion in<br />
2009 (i.e. a slight increase).<br />
2<br />
Despite <strong>the</strong> economic crisis, software vendors have<br />
demonstrated that <strong>the</strong>y constitute a strategic and<br />
astonishingly resilient industry. The software industry<br />
is growing and has bounced back quickly (with a 8.4%<br />
increase in total turnover in 2009). With 3.8bn€<br />
invested in R&D and 54 000 highly qualified R&D jobs<br />
<strong>the</strong>y constitute a strategic industry that is critical for<br />
job creation & GDP growth in Europe. European<br />
governments must accentuate supporting measures<br />
so that this industry can create more jobs. Europe's<br />
industrial future, economic growth and technological<br />
independence rely on its ability to develop a<br />
sustainable software industry" stated Bernard‐Louis<br />
Roques, General Partner and co‐Founder of <strong>Truffle</strong><br />
<strong>Capital</strong>.<br />
• The number of R&D jobs rose slightly, from 52,020 in<br />
2008 to 54,180 in 2009.<br />
• <strong>In</strong> 2009, 74% of <strong>the</strong> <strong>Truffle</strong> 100 Europe firms were<br />
listed on one or more stock markets and accounted<br />
for 88.9% of sales, 88.7% of <strong>the</strong> R&D and 95.6% of<br />
profits.<br />
• R&D investment increased from €3.64 billion in 2008<br />
to €3.82 billion in 2009 (a 4.8% increase after a 3%<br />
drop between 2007 and 2008).<br />
The measures most requested by surveyed software firms throughout Europe were fiscal incentives (such as research<br />
tax credits), followed by public R&D funding, Small Business Acts and increased venture capital investment.<br />
TRUFFLE IN THE NEWS<br />
Sandrine Gasnot joins <strong>Truffle</strong> <strong>Capital</strong>’s team as Fund Controller<br />
Sandrine joined <strong>Truffle</strong> <strong>Capital</strong> in May 2010 as Fund Controller, bringing 20 years of<br />
experience in finance to <strong>the</strong> team. <strong>In</strong> 1987, Sandrine Gasnot worked in financial<br />
markets at ABN Amro Bank. Then she joined HSBC, one of <strong>the</strong> top global groups<br />
specialized in banking and financial services. <strong>In</strong> 2008, she expanded her experience in<br />
<strong>the</strong> banking field by joining CACEIS Bank, one of France’s biggest depositary and fund<br />
administrator.<br />
Having worked in back‐office teams in international and French financial markets, she<br />
has knowledge of not only <strong>the</strong> domestic but also <strong>the</strong> global financial sector.
PORTFOLIO NEWS<br />
N°17 October 2010<br />
• <strong>In</strong>formation Technology<br />
<strong>In</strong> brief<br />
PeopleCube is a leading provider of on‐demand calendaring, resource and facilities management software<br />
solutions for medium and large enterprises worldwide. They signed over a dozen Fortune 1000 companies as<br />
clients since January 2010, including Deutsche Bank, Thomson Reuters, Blackrock Financial, Morgan Stanley,<br />
Southwestern Energy, Spawar, Merck...) and continue innovating with <strong>the</strong>ir new business intelligence and<br />
subscription packages.<br />
MoMac delivers iPad and iPhone Apps for <strong>the</strong> leading French magazine l'Express and launches a new mobile<br />
internet portal for MSN<br />
L'Express, founded in 1953, is one of <strong>the</strong> leading<br />
French weekly <strong>news</strong> magazines, published in Paris.<br />
Its website http://www.lexpress.fr is also one of <strong>the</strong><br />
largest media websites, ga<strong>the</strong>ring 8.6 million visits<br />
per month.<br />
MoMac, via its Paris‐based subsidiary, was selected<br />
to design and build <strong>the</strong> iPhone and iPad applications<br />
for l'Express. The company responded to L’Express’<br />
quest for a slick and clear design that could embed<br />
various types of content: articles, graphics,<br />
slideshows and videos.<br />
3<br />
The result: a set of applications that have become<br />
one of <strong>the</strong> best cases in <strong>news</strong> applications on <strong>the</strong><br />
AppStore and are now used daily by thousands of<br />
iPhone and iPad owners.<br />
Produced entirely at MoMac, <strong>the</strong>se applications<br />
cover <strong>the</strong> following features:<br />
� News articles in several categories: world and<br />
domestic <strong>news</strong>, politics, business, lifestyle...<br />
� Easy browsing though articles, just like turning<br />
pages<br />
� Exclusive photos slideshows<br />
� Daily video feeds by Chief Editor Christophe<br />
Barbier<br />
� Offline content synchronisation<br />
� Sharing articles on Facebook, twitter, or via email<br />
MoMac was also selected to work with MSN to<br />
launch of <strong>the</strong>ir new mobile internet portal. MSN.nl is<br />
<strong>the</strong> Dutch destination for global digital giant MSN,<br />
and one of <strong>the</strong> leading internet destinations in <strong>the</strong><br />
Ne<strong>the</strong>rlands.<br />
<strong>In</strong> response to rapidly increasing visits from mobile<br />
users across Holland, MSN decided to upgrade <strong>the</strong>ir<br />
mobile experience, with a state‐of‐<strong>the</strong>‐art mobile<br />
website, that had to meet <strong>the</strong> following objectives:
N°17 October 2010<br />
� Offer users a comprehensive range of content and<br />
functionality, including all of <strong>the</strong> existing MSN<br />
services, in addition to <strong>the</strong> most compelling <strong>news</strong><br />
and entertainment<br />
� Present a rich intuitive user experience that struck<br />
a balance between simplicity, design and fast<br />
page display<br />
Keyyo: acquisition of Mobeel Group, a Mobile Virtual Network Operator (MVNO)<br />
Keyyo, a VoIP operator, recently acquired 100% of<br />
Mobeel Group’s capital. Mobeel, a new arrival on <strong>the</strong><br />
French market, is a mobile virtual network operator<br />
offering competively‐priced mobile calling plans via a<br />
purely‐online distribution model.<br />
• Life Sciences<br />
Neovacs, a biotech company focused on an active<br />
immuno<strong>the</strong>rapy technology with applications in <strong>the</strong><br />
treatment of autoimmune diseases, inflammatory<br />
diseases and cancer, announced that its TNF‐Kinoid<br />
product candidate has been selected by Windhover,<br />
an international pharmaceutical and healthcare<br />
information company, as one of <strong>the</strong> top ten projects<br />
to watch in <strong>the</strong> inflammatory/autoimmune area.<br />
<strong>In</strong> addition, Neovacs will present its TNF‐Kinoid<br />
programs and notably <strong>the</strong> results of a Phase 1/2<br />
4<br />
� Provide flexibility for MSN to rapidly change and<br />
update <strong>the</strong> portal ensuring <strong>the</strong> offering was<br />
always fresh and appealing<br />
� Finally, as a leading B2C services supplier, ensure<br />
optimized mobile rendering for 100% of <strong>the</strong>ir<br />
users handsets<br />
The acquisition enables Keyyo to enlarge its VOIP<br />
offer to business customers with a mobile plan, while<br />
also benefitting from Mobeel’s e‐commerce<br />
expertise to cross‐sell to <strong>the</strong> company’s existing<br />
client base.<br />
study in 21 patients with Crohn’s Disease, at <strong>the</strong><br />
Therapeutic Area Partnerships meeting, which will<br />
take place at <strong>the</strong> Westin Copley Place in Boston, MA.<br />
from 2 to 4 November 2010.<br />
The TNF‐Kinoid is in phase 2 testing in rheumatoid<br />
arthritis.<br />
The company is also advancing in <strong>the</strong> Phase I/II<br />
international trial of a second product candidate, IFN<br />
‐Kinoid, dedicated to <strong>the</strong> treatment of lupus.
N°17 October 2010<br />
Carmat, <strong>the</strong> designer and developer of <strong>the</strong> world’s<br />
most advanced total artificial heart, had its Scientific<br />
Advisory Board meet on September 12 at <strong>the</strong> venue<br />
of <strong>the</strong> 24 th Annual Meeting of <strong>the</strong> European<br />
Association for Cardiothoracic Surgery (EACTS) in<br />
Geneva (Switzerland). The Scientific Advisory Board<br />
(chaired by Professor Alain Carpentier) discussed <strong>the</strong><br />
Symetis, a company developing new transca<strong>the</strong>ter<br />
aortic valve implantation (TAVI) systems, recently<br />
completed patient enrolment in its ACURATE TA<br />
first‐in‐man (FIM) clinical study and positive<br />
preliminary results. ACURATE TA is a self‐aligning<br />
nitinol stent valve designed for optimal trans‐apical<br />
delivery, providing <strong>the</strong> physician with unmatched<br />
positioning tolerance and ease of use. The study was<br />
5<br />
preparation of Carmat's clinical trials through to <strong>the</strong><br />
end of 2011. <strong>In</strong> July, Carmat successfully listed on <strong>the</strong><br />
Alternext market of NYSE Euronext, with a view to<br />
performing <strong>the</strong> first implantation of its total artificial<br />
heart in a patient in 2011 and commercializing <strong>the</strong><br />
device by 2013.<br />
conducted on 40 patients and is <strong>the</strong> largest 2nd<br />
generation First <strong>In</strong> Man (FIM) study ever conducted.<br />
Successful valve implantation with <strong>the</strong> ACURATE TA<br />
was done in 38 patients (95.0%). Symetis will soon<br />
begin a pilot clinical study, a major step toward<br />
achieving European compliance and <strong>the</strong> CE mark. The<br />
company has just received 25 million Swiss Francs in<br />
a new round of financing, mainly from <strong>Truffle</strong> <strong>Capital</strong>.<br />
Deinove, <strong>the</strong> biofuels and green chemistry specialist, partners with VTT Technical Research Centre of<br />
Finland having a Centre of Excellence in White Biotechnology ‐ Green Chemistry<br />
Deinove, <strong>the</strong> world's leading specialist in <strong>the</strong><br />
application of deinococci bacteria to biofuels and<br />
green chemistry, partnered in July with <strong>the</strong> top<br />
European research centre on industrial enzymes and<br />
bioprocesses, VTT Technical Research Centre of<br />
Finland.<br />
Ten senior VTT researchers will team up with Deinove<br />
and its French academic partners from CNRS and<br />
INSA to leverage <strong>the</strong> exceptional properties of<br />
Deinococcus bacteria in <strong>the</strong> digestion of biomass and<br />
<strong>the</strong> development of an integrated process for <strong>the</strong><br />
bioproduction of ethanol and chemicals from<br />
renewable feedstocks.<br />
The general objective of <strong>the</strong> work plan established by<br />
Deinove and VTT is to evaluate <strong>the</strong> different<br />
Deinococcus candidate strains screened by Deinove<br />
for its cellulosic ethanol production process. The<br />
Deinol process will <strong>the</strong>n be scaled‐up and tested in an<br />
industrial pilot by <strong>the</strong> sugar‐company TEREOS.<br />
Deinove also received in September <strong>the</strong> first<br />
installment granted by <strong>the</strong> French <strong>In</strong>novation Agency<br />
Oseo (Strategic <strong>In</strong>dustrial <strong>In</strong>novation programme) to<br />
<strong>the</strong> Deinol project for <strong>the</strong> production of cellulosic<br />
ethanol using <strong>the</strong> Deinococcus. The payment by Oseo<br />
of <strong>the</strong> first installment, of € 1,4 million out of a total<br />
of €6 million funding granted to <strong>the</strong> DEINOL<br />
project,aims at opening up (by 2014) new pathways<br />
for lignocellulosic ("second‐generation") ethanol<br />
production in existing industrial installations.<br />
Deinove also appointed Philippe Duval (Chairman of<br />
<strong>the</strong> Executive Board at Tereos, Deinove’s partner and<br />
investor in Deinove’s IPO) to its Board of Directors.
• Energy<br />
<strong>In</strong> brief<br />
N°17 October 2010<br />
The Crown Estate, a British organization with a property portfolio encompassing many of <strong>the</strong> UK’s cityscapes,<br />
ancient forests, farms, parkland, coastline and communities, has awarded 2‐B Energy <strong>the</strong> right to demonstrate<br />
2B‐Energy’s two offshore wind turbines in Scotland. 2B‐Energy’ will launch offshore wind demonstration sites<br />
to begin initial survey and consultation processes for <strong>the</strong>ir sites while <strong>the</strong> Scottish Government conducts a<br />
Strategic Environmental Assessment (SEA) for offshore wind within Scottish territorial waters.<br />
SP3H, a leader in <strong>the</strong> field of fuel profiling, which recently raised €2,3 million in January from <strong>Truffle</strong> <strong>Capital</strong>,<br />
launched a fuel sensor called Niris, based on SP3H’s technology, HCP (HydroCarbon Profiler technology). SP3H<br />
launched Niris in partnership with CMR for marine and heavy duty. SP3H also received <strong>the</strong> 2010 GEP<br />
<strong>In</strong>novation Award for SMEs, which acknowledges SP3H’s technology and <strong>the</strong>ir open innovation strategy.<br />
<strong>Truffle</strong> <strong>Capital</strong> makes three new investments in <strong>the</strong> energy sector<br />
<strong>In</strong> September, <strong>Truffle</strong> <strong>Capital</strong> concluded three new investments in <strong>the</strong>se particularly promising energy<br />
companies:<br />
• Neelogy develops and commercialises innovative magnetic sensors. The company's technology enables<br />
<strong>the</strong> high‐precision measurement of DC and AC currents in complex environments. The lightweight,<br />
flexible sensors are very well suited to emerging needs for improved energy efficiency: energy<br />
measurement, battery management, <strong>the</strong> mass reduction of static converters and electric motor<br />
control and diagnostics.<br />
<strong>Truffle</strong> <strong>Capital</strong> has invested €3 million in a second round of financing which will enable Neelogy to fund<br />
its investments and collaborative R&D programmes with specialists in <strong>the</strong> fields of energy conversion,<br />
<strong>the</strong> protection of DC installations and <strong>the</strong> measurement of AC energy.<br />
• The start‐up Acerde was founded in 2006 by Didier Pique. It is developing and leveraging its expertise<br />
in <strong>the</strong> design and formulation of materials with high‐performance qualities, based on high‐<br />
temperature chemical vapour deposition. The first application of Acerde's technology concerns X‐ray<br />
tube anodes and could turn <strong>the</strong> company into a key partner for computed tomography scanner<br />
manufacturers.<br />
<strong>Truffle</strong> <strong>Capital</strong> has invested €1.5 million in <strong>the</strong> company's first round of financing, so that Acerde can<br />
develop its technology for X‐ray tube anodes and thus generate short‐term revenue.<br />
6
N°17 October 2010<br />
• Actility was founded in 2010 by IT industry veteran Olivier Hersent. It is developing a machine‐to‐<br />
machine communication platform for new‐generation telecom networks. The goal is to develop client<br />
solutions through <strong>the</strong> use of communication platforms which will generate revenues for <strong>the</strong> company<br />
via software, accessories and licensing.<br />
<strong>Truffle</strong> <strong>Capital</strong> has invested €3 million in <strong>the</strong> company's first round of financing, in order to fund <strong>the</strong><br />
company's first communication platform (due to be operational in 2011).<br />
RF‐iT Solutions optimizes retail processes of Gerry Weber brand, thanks to new detego® RFID Starter Kit, a<br />
package for directly managing stocks.<br />
RF‐iT Solutions, a leading European provider of integrated RFID solutions offering standard modules for <strong>the</strong><br />
optimization of business processes in fashion industry, in partnership with Pranke GmbH, have created a<br />
package for directly managing stocks using <strong>the</strong> innovative RFID technology in <strong>the</strong> retail industry.<br />
Since this summer on, all items from <strong>the</strong> lifestyle company Gerry Weber will be equipped with RFID tags. As a<br />
result, each retailer who sells Gerry Weber products can now also benefit from this technology.<br />
Benefits of this product are multiple: improvement in inventory management, <strong>the</strong> supplier can quickly detect<br />
an out of stock situation and close it immediately. Retailers can register all deliveries and <strong>the</strong> current<br />
inventory with a hand‐held device and automatically check for completeness. Customers who can find <strong>the</strong>ir<br />
preferred products at <strong>the</strong> shop are satisfied customers who come back and display tremendous brand loyalty.<br />
Starter kits were presented in June at Gerry Weber’s franchisers and found a very positive response: "The<br />
RFID Starter kit provides a quick and efficient entry into an RFID‐based inventory management for our<br />
retailers and that in all major European languages", ensures Dr. David Frink, managing director of IT, logistics<br />
and production at Gerry Weber.<br />
More than 340 Houses of Gerry Weber, over 1,860 shop‐in‐shops as well as several mono‐brand online shops<br />
successfully showcase <strong>the</strong> brands of Gerry Weber <strong>In</strong>ternational AG to consumers worldwide. Today, <strong>the</strong> five<br />
brands are managed and designed under <strong>the</strong> umbrella of <strong>the</strong> holding company in Halle. Licensed products<br />
such as shoes and bags complement <strong>the</strong> range and <strong>the</strong> versatile fashion strikes <strong>the</strong> same chord with<br />
customers, whe<strong>the</strong>r in Berlin, Dubai or Ottawa. That is how Gerry Weber became listed on <strong>the</strong> stock exchange<br />
and a worldwide known fashion and lifestyle company.<br />
7
CONTACTS<br />
<strong>In</strong>vestor Relations<br />
Sneha HIREMATH<br />
<strong>Truffle</strong> <strong>Capital</strong><br />
5 rue de la Baume<br />
75008 Paris<br />
Email:<br />
sneha@truffle.com<br />
Web : www.truffle.com<br />
N°17 October 2010<br />
8<br />
Press Relations<br />
Caroline CARMAGNOL<br />
Alize RP<br />
33, rue de Surène<br />
75008 Paris<br />
Tel: +33 42 68 86 43<br />
Mob: + 33 6 64 18 99 59<br />
Fax. : +33 1 42 68 06 51<br />
Email: caroline@alizerp.com